BTCY Biotricity, Inc.

P/E --
Forward P/E -0.2888372
Price/Sales 0.1532345
Beta 1.151
Div Yield --
Market Cap --

Company Analysis

Latest News

🟢 Biotricity is trading 5.56% up today without an identified catalyst

Biotricity is trading at $0.10, up 5.56%, without an identified company-specific catalyst. - No new company-specific announcement or major catalyst was...

🟢 Biotricity is trading 11.11% up today as August CPI matched expectations

Biotricity is trading 11.11% up at $0.10 as broad U.S. markets rally after August CPI matched expectations, easing inflation concerns. - The Dow, S&P 500, and...

🔴 Biotricity is trading 10% down today amid broader risk-off trading

Biotricity is trading 10% down at $0.09 amid broader risk-off trading, after no clear company-specific announcement emerged for September 10, 2026. - The S&P...

🔴 Biotricity is trading 10% down today amid broader healthcare weakness

Biotricity is trading 10% down at $0.09 amid broader healthcare weakness. - Healthcare ETF XLV is down 2.19% as insurance-coverage concerns weigh on hospitals...

🔴 Biotricity is trading 5.2% down today

Biotricity is trading 5.2% down at $0.10, with no clear company-specific catalyst identified for the decline as of September 4, 2026. - Searches found no new...

🔴 Biotricity is trading 14.51% down today with no clear company-specific catalyst

Biotricity is trading at $0.09, down -14.51%, with no clear company-specific announcement identified for September 3, 2026. - Recent searches found delayed...

🔴 Biotricity is trading 16.67% down today amid Middle East-linked risk aversion

Biotricity is trading at $0.10 (-16.67%) on September 2, 2026, as broader risk aversion linked to Middle East tensions appears to weigh on its thinly traded...

🔴 Biotricity is trading 13.83% down today as U.S. equities weaken

Biotricity is trading 13.83% down now at $0.10 as U.S. equities weaken amid geopolitical tensions, higher oil prices, rising bond yields, and softer labor and...

🔴 Biotricity is trading 8.42% down today as no new catalyst was identified

Biotricity is trading at $0.11, down 8.42%, after no new company-specific catalyst was identified for August 28, 2026. • Volume is 13.59K, below the 87.34K...

🟢 Biotricity is trading 6.76% up today amid broader risk-on market sentiment

Biotricity is trading 6.76% up now at $0.12, appearing most consistent with broader risk appetite, with no clearly identified company-specific catalyst on...

🔴 Biotricity is trading 6.95% down today with no clearly reported company-specific catalyst

Biotricity is trading 6.95% down at $0.11, with no clearly reported company-specific catalyst for August 25, 2026. - On August 18, the company filed a Form...

🟢 Biotricity is trading 7.62% up today with no clear catalyst reported

Biotricity is trading $0.13 (+7.62%) now, with no clearly reported company-specific catalyst for August 24, 2026. - The August 19 Form 10-Q showed higher...

Biotricity revenue climbs to $4.28 million, faces going concern risk

Biotricity revenue climbs to $4.28 million, faces going concern risk

Biotricity, Inc. (BTCY) reported revenue of $4.28 million for the quarter ended June 30, 2026. This figure rose from $3.87 million in the prior-year period....